DUCTAL CARCINOMA IN SITU

This study tests a shorter, 5-day radiation treatment for women aged 50 and older with early-stage breast cancer or DCIS. The goal is to see if this ultra-fast approach is as safe and effective as longer courses, with fewer side effects and less disruption to daily life. About 90…

This study tests whether active monitoring with hormone therapy can safely manage ductal carcinoma in situ (DCIS), a very early form of breast cancer, instead of immediate surgery. About 400 women with hormone-sensitive DCIS will receive either standard or experimental hormone th…

This study tests whether a vaccine targeting a protein called MUC1 can help prevent breast cancer in women with ductal carcinoma in situ (DCIS), a very early stage. About 50 women will either receive standard hormone therapy alone or hormone therapy plus the MUC1 vaccine before s…

This study looks at whether a special dye called Magtrace can help women with non-invasive breast cancer (DCIS) avoid an extra surgery to remove lymph nodes. Normally, women having a mastectomy get this lymph node surgery just in case cancer has spread, but it's often not needed.…

This study tests a new tattoo ink called Magic Ink that fades away over time, used to mark the exact spot for daily radiation in women with breast cancer. About 30 participants will get the Magic Ink instead of standard permanent ink. Researchers want to see if it is safe and sti…

This study looks at how social factors like stress and support relate to inflammation in women newly diagnosed with breast cancer. About 200 participants will fill out questionnaires and give one blood sample. The goal is to understand these connections, not to test a treatment.

This study looks at a new method to mark the area where breast cancer was removed during surgery. The goal is to help radiation doctors see the exact spot on scans so they can aim radiation more precisely. It also aims to reduce the need for repeat surgeries when cancer cells are…